This website is provided by UniDoc Health Corp (“UniDoc”). The statements and communications contained in the UniDoc website are intended for information only. None of them constitutes a solicitation, an offer or a recommendation to buy or sell securities, or to conduct other transactions.
No warranty, either express, or implied, is given for the information and opinions published on the website. Actions based on statements made therein are the responsibility of those who take them. UniDoc therefore disclaims all liability for damage which may result directly and indirectly from the use, performance or consultation of the UniDoc web site, in connection with access to the website itself or other websites linked to it.
This website contains certain “forward-looking statements.” Such forward-looking statements are sometimes identified by words such as “intends,” “anticipates,” “believes,” “expects” and “hopes” and include, without limitation, statements regarding UniDoc’s plan of business operations, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures and involve a number of risks and uncertainties that could cause actual results to differ materially from projected results. Such factors include, among others, the willingness and ability of third parties to honor their contractual obligations, the decisions of third parties over which UniDoc has no control, commodity prices, environmental and government regulations, availability of financing, judicial proceedings, force majeure events, and other such risk factors. Many of these factors are beyond UniDoc’s ability to control or predict. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, UniDoc disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.
Nothing on this website is either an offer to purchase, or a solicitation of an offer to sell, shares of UniDoc or any other entity. Nothing on this website is a solicitation of a proxy from a security holder of UniDoc or any other company.
UniDoc shall not be liable for any claims, expenses, damages (including direct, indirect, special or consequential damages), and loss of profits, opportunities or information arising from: the use of or reliance on information contained in this website; any inaccuracy or omission in such information or failure to keep the information current; use of any third party websites linked to this website; any Internet software used in connection with this website or computer viruses or other destructive programs encountered as a result of using this website; and any other matter connected with this website; even if UniDoc is made aware of the possibility of such claims, expenses, damages or losses.
Due to technical difficulties inherent in the Internet, Internet software or transmission problems could produce inaccurate or incomplete copies of information contained on this website. Computer viruses or other destructive programs may also be inadvertently downloaded from the website. UniDoc shall not be liable for Internet software, computer viruses or destructive programs and recommends that you install appropriate anti-virus or other protective software.
UniDoc provides links to third party websites for your convenience only and the inclusion of these links does not imply that UniDoc monitors or endorses these websites. Accordingly, UniDoc accepts no responsibility for such websites.
This website is not intended as a solicitation or offering of securities in any jurisdiction and the information contained herein in no way should be construed or interpreted as such. No securities commission or other regulatory authority in the United States, Canada or any other country or jurisdiction has in any way passed upon this information and no representation or warranty is made by UniDoc to that effect. The information on this website should not be used for the purpose of making investment decisions concerning UniDoc securities. Printed copies of public disclosure documents may be obtained directly from UniDoc Investor Relations.
UniDoc, its affiliates and third-party providers are not responsible for any errors or omissions in the information contained on or accessed through this Site. All such information in this Site is provided “as is”. UniDoc, its affiliates and third-party providers make no warranties or representations and disclaim all express, implied and statutory warranties of any kind to the user and any third party, including, but not limited to, any warranties of accuracy, timeliness, completeness, merchantability, non-infringement and fitness for any particular purpose.
Except for claims that cannot be excluded by the applicable local law, UniDoc, its affiliates and third-party providers shall not have any liability, including but not limited to, tort, contract or any other liability to user or any third party arising as a result of use of or access to this Site.
UniDoc, its affiliates or third-party providers shall not be liable to user or any third party for lost profits or lost opportunity, direct, indirect, special, consequential, incidental or punitive damages whatsoever, even if UniDoc, its affiliates or third-party providers have been advised of the possibility of such damages.
Some jurisdictions do not allow for the exclusion or limitation of implied warranties or liability for incidental or consequential damages. Therefore, the above limitations may not apply to you, or there may be applicable laws which supersede the above. Any clause of this disclaimer declared invalid by the appropriate authority in each jurisdiction shall be deemed severable and shall not affect the validity or enforceability of the remainder of this disclaimer. UniDoc reserves the right to amend the document at its discretion at any time without notice.
"*" indicates required fields
Enter your details below and we will add you to our News Alerts list.
Mr. Caon is an elected member of the Italian Parliament. Since 2013, he has been a Member of the Italian Republic with the functions of: member of the Transport, Digitization, and Communications Commission of the Italian Parliament, member of the Bicameral Commission for Regional Affairs, and member of the Agriculture Commission. In Parliament, counted among his numerous successes, he has assisted with the implementation of various telemedicine services in the family sector. He has done this through the identification of innovative processes for patient care and the strengthening of multi-professional and multidisciplinary collaboration between different professionals. This work is now included in the proposed National Recovery and Resilience Plan, the 750 billion European plan that the member countries will use for the recovery of national economies, severely tested by the effects of the Covid-19 pandemic.
Prior to his current role in the Italian Parliament, Mr. Caon has spent over 30 years as an entrepreneur coordinating and designing solutions and technologies in the engineering, automotive and manufacturing sectors that are currently employed in 34 countries and used by hundreds of companies in both B2B and B2B2C environments. He held the role of owner and administrator of Giorgia Srl., a small / medium company active in the automotive and manufacturing engineering sector. He has worked extensively in the development of foreign markets for various companies in the metalworking and manufacturing sectors. He is currently a member of many trade associations linked to his extensive personal entrepreneurial background.
Mr. Pirooz is a registered and practicing pharmacist, and has been a professional member of the College of Pharmacists of British Columbia since 2003, with over 20 years of pharmaceuticals and pharmacy management experience. As owner of a compounding pharmacy, Mr. Pirooz has been dispensing pharmaceuticals for over 18 years and provides pharmacist and pharmacy management services to many of Canada’s largest pharmacy chains and drug stores. Mr. Pirooz is also the CEO and a director of Genix Pharmaceuticals Corporation, a company listed for trading on the TSXV.
He is the former Chief Scientific Officer of InMed Pharmaceuticals Inc., a leading public Canadian bio-pharmaceutical company. Previously he worked as Senior Scientist at Biotechnology Research Institute of National Research Council Canada. Working with the Canadian government he helped establish the pharmacology laboratory to evaluate safety and efficacy of cannabinoid-based and other drugs under development for cancer, cardiovascular and ocular diseases.
Jacob is the CEO & founder of MoviWear a GPS, fall down detection & remote vital-sign monitoring platform, alerting caregivers of real-time emergencies. Jacob is a communications and technology expert with over 15 years’ experience in the field. the NurtureWatch health monitoring Smartwatch and MoviWearMED remote vital sign monitoring platform Prior to MoviWear, Jacob worked in both the Canadian telecom and the CPG industry. He led the Product Development and Business Strategy team at TELUS for the Small Business Portfolio. Jacob also worked in various product and service management roles within Rogers Communications where he launched and managed wireless and wireline products.
Mr. Baldassarre has held senior management and director positions of new business start-ups and established multinational organizations with over 30 years of experience in the Security, Information Technology and Communications industries. With leadership skills in management of international operations, shareholder exit strategies, and overall business development, he has utilized a wide range of strategic programs to maximize organic growth into specific industry segments through OEM, alliances, and direct multi-level distribution channels. Mr. Baldassarre is able to plan, organize and direct all aspects of a Corporation from Operations, P&L oversight, product distribution, Product promotions, sales and development activities and initiatives utilizing my extensive marketing/sales senior management experience with developed abilities in team leadership and program/campaign development. Directly involved in the growth, branding and ultimately optimizing market share, product awareness, revenues, profitability and shareholder value. Mr. Baldassare is also the President of LRG Security Canada Inc. and LRG Security Europe.
Mr. Franco Staino is the Developer of the Italian National anti-counterfeiting Program for Pharmaceuticals developed in conjunction with the Ministry of Health as well as the National Certification Program for all unsold Prescription Drugs in Partnership with Pharmindustria (National association of all Pharmaceutical Manufactures) through ASSINDE.
Through one of his Companies, Carlucci are responsible for the control, labelling and collection of all pharmaceutical prescription drugs in Italy, under the PHG umbrella Franco opened first a UK division, now has also expanded into 4 African countries. Over the Years Franco has been a Board Member and Contributor on various International Committees, including the United Nations.